Trinity Biotech (TRIB) Reports Q4 Loss of $0.23/sh

Trinity Biotech (NASDAQ: TRIB) reported Q4 EPS of ($0.23), versus $0.60 reported last year. Revenue for the quarter came in at $19.5 million versus the consensus estimate of $22 million.

For earnings history and earnings-related data on Trinity Biotech (TRIB) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c